This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Colm O'Dushlaine: Innovator in Liver Disease Treatment
Introduction
Colm O'Dushlaine is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of liver disease. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Colm O'Dushlaine holds a patent for the "Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors." This patent outlines methods for treating subjects with liver disease and identifying individuals at an increased risk of developing this condition. His work in this area is crucial for advancing medical treatments and improving patient outcomes.
Career Highlights
Colm is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to engage in groundbreaking research. His role at this esteemed company allows him to collaborate with other leading scientists and contribute to innovative solutions in healthcare.
Collaborations
Throughout his career, Colm has worked alongside talented colleagues, including Niek Verweij and Aris I Baras. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Colm O'Dushlaine's contributions to the treatment of liver disease exemplify the impact of innovation in medicine. His patent and ongoing work at Regeneron Pharmaceuticals, Inc. highlight his commitment to improving health outcomes for patients.